Skip to Main Content

Paper Details

The OPTIMIZE randomized trial to assess safety and efficacy of the Svelte IDS and RX Sirolimus-eluting coronary stent Systems for the Treatment of atherosclerotic lesions: Trial design and rationale.
Am Heart J
2
2019
Author NameAffiliation
Laura MauriHarvard Medical School.
David J CohenSaint Luke's Mid America Heart Institute
  • 1 - 2

Datasets

Release 1.2